4Filing Date: Sep 10, 2026
Metlife
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001283051-26-000013
Total Value$59.0K
Trades1
Insiders1
Transaction Details
HUBBARD ROBERT GLENN
Director·Direct
Grant · Acquire
Common Stock
Shares+618
Price$95.50
Total Value$59.0K
Shares Owned After108.19K
Transaction DateSep 8, 2026
Footnotes ▸
Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
Post-Transaction Holdings
HUBBARD ROBERT GLENN · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 108.19K | +618 (0.57%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-08
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: METLIFE INC (MET)
CIK: 0001099219
--- Reporting Owner ---
Name: HUBBARD ROBERT GLENN
CIK: 0001283051
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-08 | Code: A (Grant or award)
Shares: +618 | Price: $95.50
Total Value: $59,019.00
Shares Owned After: 108,191 | Ownership: D (Direct)
Footnotes:
[F1] Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
--- Footnotes (Complete Index) ---
F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
--- Signature ---
/s/ /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact (2026-09-10)